Amakhandlela eVaginal Panavir

I-suppanaire yeVaginal I-Panavir yinto yemveliso yemveliso yasekhaya. I-Panavir i-immunomodulatory, kunye ne-agent antiviral yemvelaphi yemvelo. I-Panavir ikwandisa ukumelana nomzimba kwizifo ezahlukeneyo. Emva kwenkqubo enye yonyango olubanzi, apho isilwanyana esasetyenzisiweyo, ukuphuhliswa kokuphindaphinda kwizinto eziphawulweyo kuncipha kakhulu, kwaye ekugqibeleni kukhulula ngaphezu kweesibhozo ezisibhozo zebonke abaye bafumana.

Iimpawu zokusetyenziswa kwamakhandlela iPanavir

Kwizinyathelo zomzimba, i-Panavir imiselwe kula maxesha alandelayo:

Oogqirha banika i-suppositories ye-vaginal ye-Panavir kwi-HPV. Yethula ikhandlela i-Panavir kwisisu emva kobusuku, ngaphambi kokuba ulale kwaye unzulu ngendlela enokwenzeka. I-Panavir ayinayo i-allergen, okanye i-carcinogenic, okanye i-embryotoxic izenzo.

I-Panavir ibhekisela kwi-hexose glycosides, iphezulu ye-molecular weight polysaccharide. Iyakunyamezela kakuhle kwiindlela ezicetyiswayo.

Umyinge wePanavir uxhomekeke kubukhulu beempawu zesifo esithile sentsholongwane.

Akuyimfuneko ukugwema ukusebenzisa imichiza kwiintsuku ezibalulekileyo. Ngokusekelwe apha ngasentla, musa ukuphazamisa inkqubo yonyango ngamakhandlela iPanavir ngexesha lokuya esikhathini.

Ukungqinelana nokusetyenziswa kwamakhandlela iPanavir

I-Panavir inokuphikisana kwayo - okokuqala, kukuqala, konke ukuphakama okukhulu kwinqanaba elithile lobunzima bezilwanyana, kwaye lichazwe kwi-pathology ye-renal ne-patleen pathology. Amakhandlela e-Panavir ekukhulelwe ayanconywa. Ngethuba lokutya, oogqirha bayacetyiswa ukuba baphumele kule nkunkuma, nangona akukho nto ipapashwa, ngokucacileyo ukuba kukho unyango olukhoyo kubisi lonina.